The B-Raf status of tumor cells may be a significant determinant of both antitumor and anti-angiogenic effects of pazopanib in xenograft tumor models (Q28744228)
Jump to navigation
Jump to search
scientific article (publication date: 2011)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The B-Raf status of tumor cells may be a significant determinant of both antitumor and anti-angiogenic effects of pazopanib in xenograft tumor models |
scientific article (publication date: 2011) |
Statements
The B-Raf status of tumor cells may be a significant determinant of both antitumor and anti-angiogenic effects of pazopanib in xenograft tumor models (English)
0 references
2011
0 references
6
0 references
10
0 references
e25625
0 references
5 October 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference